{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:01:16Z","timestamp":1791194476988,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":51,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd009219.pub3","type":"reference-entry","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T00:02:46Z","timestamp":1404259366000},"source":"Crossref","is-referenced-by-count":12,"title":["Medical interventions for the prevention of platinum-induced hearing loss in children with cancer"],"prefix":"10.1002","author":[{"given":"Jorrit W","family":"van As","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira C","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD009219.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/08880010701451244","article-title":"Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin","volume":"24","author":"Gallegos-Castorena","year":"2007","journal-title":"Pediatric Hematology and Oncology"},{"issue":"24","key":"10.1002\/14651858.CD009219.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1002\/cncr.24667","article-title":"Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group","volume":"115","author":"Katzenstein","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD009219.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00043426-200203000-00006","article-title":"Use of amifostine in the therapy of osteosarcoma in children and adolescents","volume":"24","author":"Petrilli","year":"2002","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"7","key":"10.1002\/14651858.CD009219.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1200\/JCO.2005.03.5352","article-title":"Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival","volume":"24","author":"Petrilli","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD009219.pub3-BIB5|cit5","first-page":"493","article-title":"Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors","volume":"7","author":"Doolittle","year":"2001","journal-title":"Clinical Cancer Research"},{"issue":"1-2","key":"10.1002\/14651858.CD009219.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1383-5718(01)00278-9","article-title":"Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo","volume":"498","author":"Elsendoorn","year":"2001","journal-title":"Mutation Research"},{"issue":"22","key":"10.1002\/14651858.CD009219.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2007.14.3974","article-title":"Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma","volume":"26","author":"Fouladi","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD009219.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.bjc.6602740","article-title":"Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies","volume":"93","author":"Geoerger","year":"2005","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD009219.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2125.1996.39114.x","article-title":"Calcium supplementation and ototoxicity in patients receiving cisplatin","volume":"42","author":"Grau","year":"1996","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD009219.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2273.1986.tb00144.x","article-title":"Assessment of the effect of chemotherapy and radiotherapy on the auditory function of children with cancer","volume":"11","author":"Kingston","year":"1986","journal-title":"Clinical Otolaryngology and Allied Sciences"},{"issue":"4 Suppl Nurse E","key":"10.1002\/14651858.CD009219.pub3-BIB11|cit11","first-page":"35","article-title":"Hearing loss in pediatric cancer survivors treated with cisplatin","volume":"22","author":"Knight","year":"2008","journal-title":"Oncology (Williston Park)"},{"key":"10.1002\/14651858.CD009219.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1200\/JCO.2009.27.3524","article-title":"Randomized trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1\/SIOPEN study","volume":"28","author":"Ladenstein","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD009219.pub3-BIB13|cit13","first-page":"26","article-title":"Cis-platinum (CDDP) ototoxicity in pediatric patients","author":"Mahoney","year":"1982","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD009219.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0022-3476(83)80747-1","article-title":"Ototoxicity with cisplatin therapy","volume":"103","author":"Mahoney","year":"1983","journal-title":"The Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD009219.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/cncr.21218","article-title":"Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study","volume":"104","author":"Marina","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1002\/14651858.CD009219.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-3476(83)80551-4","article-title":"Hearing loss in children receiving cisplatin chemotherapy","volume":"102","author":"McHaney","year":"1983","journal-title":"The Journal of Pediatrics"},{"key":"10.1002\/14651858.CD009219.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/b109924_13","article-title":"Auditory late effects of chemotherapy","volume":"150","author":"Meyer","year":"2009","journal-title":"Cancer Treatment and Research"},{"issue":"6","key":"10.1002\/14651858.CD009219.pub3-BIB18|cit18","first-page":"871","article-title":"Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man","volume":"58","author":"Piel","year":"1974","journal-title":"Cancer Chemotherapy Reports"},{"issue":"2","key":"10.1002\/14651858.CD009219.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/pbc.20627","article-title":"Preventing platinum-induced ototoxicity in children-is there a potential role for sodium thiosulfate?","volume":"47","author":"Skinner","year":"2006","journal-title":"Pediatric Blood and Cancer"},{"issue":"16","key":"10.1002\/14651858.CD009219.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1200\/JCO.2006.08.2388","article-title":"Phase I clinical trial of oxaliplatin in children and adolescents with refractory solid tumors","volume":"25","author":"Spunt","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"24","key":"10.1002\/14651858.CD009219.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1002\/cncr.24668","article-title":"Hepatoblastoma, cisplatin, and ototoxicity: good news on deaf ears","volume":"115","author":"Sullivan","year":"2009","journal-title":"Cancer"},{"issue":"11","key":"10.1002\/14651858.CD009219.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2004.02.029","article-title":"Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study","volume":"40","author":"Weijl","year":"2004","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD009219.pub3-BIB23|cit23","unstructured":"Phase III randomized study of sodium thiosulfate in preventing ototoxicity in young patients receiving cisplatin chemotherapy for newly diagnosed germ cell tumor, hepatoblastoma, medulloblastoma, osteosarcoma, or other malignancy www.cancer.gov"},{"key":"10.1002\/14651858.CD009219.pub3-BIB24|cit24","unstructured":"A multicentre open label randomised phase III trial of the efficacy of sodium thiosulfate in reducing ototoxicity in patients receiving cisplatin chemotherapy for standard risk hepatoblastoma www.controlled-trials.com"},{"issue":"10","key":"10.1002\/14651858.CD009219.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"4","key":"10.1002\/14651858.CD009219.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: a practical grading system","volume":"19","author":"Brock","year":"1991","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD009219.pub3-BIB27|cit27","first-page":"123","article-title":"Late effects of cancer treatment and current protective measures","volume-title":"Cancer in Children","author":"Jenney","year":"2005"},{"issue":"2","key":"10.1002\/14651858.CD009219.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPH.0b013e31815d1d83","article-title":"Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens","volume":"30","author":"Dean","year":"2008","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD009219.pub3-BIB29|cit29","unstructured":"Eloxatin Summary of Product Characteristics www.sanofi-aventis.co.uk\/products\/Eloxatin_SPC.pdf. Accessed March 2nd 2010"},{"issue":"2","key":"10.1002\/14651858.CD009219.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.2008.20.1160","article-title":"Prevention of hearing loss in children receiving cisplatin chemotherapy","volume":"27","author":"Freyer","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD009219.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-91-5-744","article-title":"Furosemide-induced ototoxicity","volume":"91","author":"Gallagher","year":"1979","journal-title":"Annals of Internal Medicine"},{"issue":"9209","key":"10.1002\/14651858.CD009219.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(00)02044-4","article-title":"Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer","volume":"355","author":"Gietema","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD009219.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1542\/pir.25-7-224","article-title":"Pediatric audiology: a review","volume":"25","author":"Gregg","year":"2004","journal-title":"Pediatrics in Review"},{"issue":"4","key":"10.1002\/14651858.CD009219.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1542\/peds.2009-1597","article-title":"Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group","volume":"125","author":"Grewal","year":"2010","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD009219.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2007-0178","article-title":"Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group","volume":"120","author":"Gurney","year":"2007","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD009219.pub3-BIB36|cit36","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"34","key":"10.1002\/14651858.CD009219.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD009219.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0197-2456(00)00046-5","article-title":"Statistical considerations in the intent-to-treat principle","volume":"21","author":"Lachin","year":"2000","journal-title":"Controlled Clinical Trials"},{"issue":"16","key":"10.1002\/14651858.CD009219.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","article-title":"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose","volume":"40","author":"Li","year":"2004","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD009219.pub3-BIB40|cit40","unstructured":"Kremer LCM van Dalen EC Moher D Caron HN Cochrane Childhood Cancer Group The Cochrane Library 2010"},{"key":"10.1002\/14651858.CD009219.pub3-BIB41|cit41","unstructured":"National Cancer Institute Common Toxicity Criteria version 2 http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm"},{"issue":"1","key":"10.1002\/14651858.CD009219.pub3-BIB42|cit42","first-page":"19","article-title":"Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration","volume":"66","author":"Reddel","year":"1982","journal-title":"Cancer Treatment Reports"},{"issue":"12","key":"10.1002\/14651858.CD009219.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.478","article-title":"Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy","volume":"41","author":"Ross","year":"2009","journal-title":"Nature Genetics"},{"issue":"1-2","key":"10.1002\/14651858.CD009219.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention","volume":"226","author":"Rybak","year":"2007","journal-title":"Hearing Research"},{"issue":"3","key":"10.1002\/14651858.CD009219.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1620\/tjem.219.177","article-title":"Cisplatin ototoxicity and protection: clinical and experimental studies","volume":"219","author":"Rybak","year":"2009","journal-title":"Tohoku Journal of Experimental Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009219.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.1989.7.6.754","article-title":"Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation","volume":"7","author":"Schell","year":"1989","journal-title":"Journal of Clinical Oncology"},{"issue":"16","key":"10.1002\/14651858.CD009219.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.ejca.2004.08.002","article-title":"Best practice in assessing ototoxicity in children with cancer","volume":"40","author":"Skinner","year":"2004","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD009219.pub3-BIB48|cit48","article-title":"Different infusion durations for preventing platinum-induced hearing loss in children with cancer","author":"As","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009219.pub3-BIB49|cit49","first-page":"2205","article-title":"Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy","volume":"7","author":"Veal","year":"2001","journal-title":"Clinical Cancer Research"},{"issue":"7","key":"10.1002\/14651858.CD009219.pub3-BIB50|cit50","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer","author":"As","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD009219.pub3-BIB51|cit51","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer","author":"As","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd009219.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009219.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:29:37Z","timestamp":1628548177000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD009219.pub3"}},"subtitle":[],"editor":[{"given":"Elvira C","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009219.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD009219.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2014,7,1]]}}}